BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21923919)

  • 1. Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter.
    van der Sluis RM; Pollakis G; van Gerven ML; Berkhout B; Jeeninga RE
    Retrovirology; 2011 Sep; 8():73. PubMed ID: 21923919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between viral Tat protein and c-Jun transcription factor in controlling LTR promoter activity in different human immunodeficiency virus type I subtypes.
    van der Sluis RM; Derking R; Breidel S; Speijer D; Berkhout B; Jeeninga RE
    J Gen Virol; 2014 Apr; 95(Pt 4):968-979. PubMed ID: 24447950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise.
    Ali H; Bhange D; Mehta K; Gohil Y; Prajapati HK; Byrareddy SN; Buch S; Ranga U
    Retrovirology; 2021 Sep; 18(1):27. PubMed ID: 34538278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Transcriptional Strength of HIV-1 Subtype C Minimizes Gene Expression Noise and Confers Stability to the Viral Latent State.
    Pal S; Jaiswal V; Nala N; Ranga U
    J Virol; 2023 Jan; 97(1):e0137622. PubMed ID: 36533949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Incompatibility between the Generic NF-κB Motif and a Subtype-Specific Sp1III Element Drives the Formation of the HIV-1 Subtype C Viral Promoter.
    Verma A; Rajagopalan P; Lotke R; Varghese R; Selvam D; Kundu TK; Ranga U
    J Virol; 2016 Aug; 90(16):7046-7065. PubMed ID: 27194770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.
    Chakraborty S; Kabi M; Ranga U
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner.
    van Opijnen T; Jeeninga RE; Boerlijst MC; Pollakis GP; Zetterberg V; Salminen M; Berkhout B
    J Virol; 2004 Apr; 78(7):3675-83. PubMed ID: 15016888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
    Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
    Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
    Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression analysis from human immunodeficiency virus type 1 subtype C promoter and construction of bicistronic reporter vectors.
    Siddappa NB; Kashi VP; Venkatramanan M; Balasiddaiah A; Jayasuryan N; Mahadevan A; Desai A; Satish KS; Shankar SK; Ravi V; Ranga U
    AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1268-78. PubMed ID: 17961115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
    Verhoef K; Sanders RW; Fontaine V; Kitajima S; Berkhout B
    J Virol; 1999 Feb; 73(2):1331-40. PubMed ID: 9882338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity in HIV-1 subtype C LTR from Brazil and Mozambique generates new transcription factor-binding sites.
    Boullosa J; Bachu M; Bila D; Ranga U; Süffert T; Sasazawa T; Tanuri A
    Viruses; 2014 Jun; 6(6):2495-504. PubMed ID: 24960272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1.
    Naghavi MH; Schwartz S; Sönnerborg A; Vahlne A
    AIDS Res Hum Retroviruses; 1999 Sep; 15(14):1293-303. PubMed ID: 10505678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin.
    Gao F; Robertson DL; Morrison SG; Hui H; Craig S; Decker J; Fultz PN; Girard M; Shaw GM; Hahn BH; Sharp PM
    J Virol; 1996 Oct; 70(10):7013-29. PubMed ID: 8794346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular specificity of HIV-1 replication can be controlled by LTR sequences.
    Reed-Inderbitzin E; Maury W
    Virology; 2003 Sep; 314(2):680-95. PubMed ID: 14554095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional Activity.
    Le Hingrat Q; Visseaux B; Bertine M; Chauveau L; Schwartz O; Collin F; Damond F; Matheron S; Descamps D; Charpentier C
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31915276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.